PTCT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $31,974,260.97

PTC Therapeutics Insider Trading History Chart

PTC Therapeutics Share Price & Price History

^$77.85

▲ +2.09 (2.76%)

As of 12/4/2025 05:00 PM ET

Days: 30 | 90 | 365

PTC Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/2/2025	Matthew B. Klein	CEO	Sell	3,428	$79.07	$271,051.96	349,964
11/25/2025	Allan Steven Jacobson	Director	Sell	14,199	$83.55	$1,186,326.45	17,451
11/25/2025	Neil Gregory Almstead	Insider	Sell	71,928	$83.44	$6,001,672.32	100,625
11/24/2025	Allan Steven Jacobson	Director	Sell	11,801	$80.14	$945,732.14	17,451
11/24/2025	Neil Gregory Almstead	Insider	Sell	35,572	$80.18	$2,852,162.96	100,625
11/21/2025	Emma Reeve	Director	Sell	10,000	$79.50	$795,000.00	6,666
11/17/2025	Mark Elliott Boulding	VP	Sell	2,812	$75.99	$213,683.88	103,901
11/12/2025	Emma Reeve	Director	Sell	7,333	$74.50	$546,308.50	6,666
10/30/2025	Emma Reeve	Director	Sell	15,666	$69.50	$1,088,787.00	6,666
10/7/2025	Mark Elliott Boulding	VP	Sell	3,375	$63.43	$214,076.25	103,901
10/6/2025	Mark Elliott Boulding	VP	Sell	2,266	$65.07	$147,448.62	103,901
10/3/2025	Allan Steven Jacobson	Director	Sell	12,000	$65.00	$780,000.00	17,451
10/3/2025	Emma Reeve	Director	Sell	25,562	$65.96	$1,686,069.52	10,332
10/3/2025	Mark Elliott Boulding	VP	Sell	22,655	$65.82	$1,491,152.10	103,901
10/3/2025	Neil Gregory Almstead	Insider	Sell	55,000	$66.05	$3,632,750.00	100,625
9/12/2025	Mark Elliott Boulding	VP	Sell	24,585	$61.34	$1,508,043.90	103,901
9/11/2025	Emma Reeve	Director	Sell	15,705	$59.50	$934,447.50	10,332
9/11/2025	Mark Elliott Boulding	VP	Sell	22,664	$61.00	$1,382,504.00	103,901
9/9/2025	David P. Southwell	Director	Sell	12,000	$58.34	$700,080.00	16,850
9/8/2025	Eric Pauwels	Insider	Sell	39,850	$56.92	$2,268,262.00	72,912
8/28/2025	Allan Steven Jacobson	Director	Sell	1,667	$50.15	$83,600.05	17,451
8/28/2025	Allan Steven Jacobson	Director	Sell	1,667	$50.15	$83,600.05	17,451
8/5/2025	Matthew B. Klein	CEO	Sell	10,739	$51.74	$555,635.86	337,767
7/15/2025	Pierre Gravier	CFO	Sell	2,516	$49.46	$124,441.36	71,920
5/16/2025	Mark Elliott Boulding	VP	Sell	883	$46.02	$40,635.66	103,901
5/15/2025	Mark Elliott Boulding	VP	Sell	1,929	$46.18	$89,081.22	103,901
4/22/2025	Matthew B. Klein	CEO	Sell	2,804	$48.74	$136,666.96	273,234
4/2/2025	Lee Scott Golden	EVP	Sell	897	$46.95	$42,114.15	75,997
3/13/2025	Stephanie S. Okey	Director	Sell	5,000	$54.00	$270,000.00	8,867
3/12/2025	Mark Elliott Boulding	VP	Sell	15,521	$53.30	$827,269.30	103,901
3/4/2025	Allan Steven Jacobson	Director	Sell	1,230	$51.52	$63,369.60	19,118
2/19/2025	Christine Marie Utter	CAO	Sell	879	$50.10	$44,037.90	63,442
2/19/2025	Eric Pauwels	CEO	Sell	1,378	$50.10	$69,037.80	85,427
2/19/2025	Lee Scott Golden	EVP	Sell	795	$50.10	$39,829.50	77,856
2/19/2025	Mark Elliott Boulding	VP	Sell	1,333	$50.10	$66,783.30	105,515
2/19/2025	Neil Gregory Almstead	Insider	Sell	1,300	$50.10	$65,130.00	101,931
2/19/2025	Pierre Gravier	CFO	Sell	1,168	$50.10	$58,516.80	75,603
1/7/2025	Christine Marie Utter	CAO	Sell	1,291	$45.34	$58,533.94	65,983
1/7/2025	Eric Pauwels	CEO	Sell	1,599	$45.34	$72,498.66	88,941
1/7/2025	Lee Scott Golden	EVP	Sell	810	$45.34	$36,725.40	79,849
1/7/2025	Mark Elliott Boulding	VP	Sell	1,543	$45.34	$69,959.62	108,846
1/7/2025	Neil Gregory Almstead	Insider	Sell	1,265	$45.34	$57,355.10	104,783
12/31/2024	Matthew B. Klein	CEO	Sell	8,279	$45.16	$373,879.64	217,528
12/2/2024	Christine Marie Utter	CAO	Sell	17,800	$51.77	$921,506.00	52,428
12/2/2024	Jerome B. Zeldis	Director	Sell	24,000	$51.50	$1,236,000.00	14,500
12/2/2024	Mark Elliott Boulding	VP	Sell	85,600	$52.26	$4,473,456.00	92,389
12/2/2024	Neil Gregory Almstead	Insider	Sell	69,550	$52.06	$3,620,773.00	86,202
7/16/2024	Pierre Gravier	CFO	Sell	2,269	$34.02	$77,191.38	53,531
5/22/2024	Jerome B. Zeldis	Director	Sell	20,000	$38.24	$764,800.00	14,500
5/7/2024	Lee Scott Golden	EVP	Sell	175	$32.82	$5,743.50	59,813
4/19/2024	Matthew B. Klein	CEO	Sell	3,361	$24.89	$83,655.29	225,807
4/17/2024	Eric Pauwels	CEO	Sell	787	$25.14	$19,785.18	67,694
4/2/2024	Lee Scott Golden	EVP	Sell	526	$28.37	$14,922.62	59,988
1/30/2024	Christine Marie Utter	CAO	Sell	318	$27.25	$8,665.50	35,528
1/30/2024	Mark Elliott Boulding	VP	Sell	794	$27.25	$21,636.50	71,189
1/30/2024	Neil Gregory Almstead	Insider	Sell	618	$27.25	$16,840.50	61,202
1/22/2024	Allan Steven Jacobson	Director	Sell	10,000	$27.38	$273,800.00	12,348
1/8/2024	Christine Marie Utter	CAO	Sell	1,188	$28.64	$34,024.32	37,499
1/8/2024	Eric Pauwels	Insider	Sell	1,569	$28.64	$44,936.16	46,612
1/8/2024	Mark Elliott Boulding	VP	Sell	1,457	$28.64	$41,728.48	73,921
1/8/2024	Matthew B. Klein	CEO	Sell	2,237	$28.64	$64,067.68	165,918
1/8/2024	Michael Schmertzler	Director	Sell	1,500	$27.81	$41,715.00	115,266
1/5/2024	Matthew B. Klein	CEO	Sell	10,107	$27.15	$274,405.05	168,155
12/12/2023	Pierre Gravier	CFO	Buy	7,700	$25.81	$198,737.00	33,700
9/6/2023	Alethia Young	Director	Sell	11,666	$39.86	$465,006.76	9,067
5/11/2023	Allan Steven Jacobson	Director	Sell	23,000	$55.08	$1,266,840.00	12,348
4/21/2023	Christine Marie Utter	CAO	Sell	4,692	$55.06	$258,341.52	38,059
4/21/2023	Emma Reeve	Director	Sell	4,328	$55.05	$238,256.40	7,200
4/18/2023	Eric Pauwels	Insider	Sell	732	$52.04	$38,093.28	64,805
4/18/2023	Matthew B. Klein	CEO	Sell	1,211	$52.04	$63,020.44	102,645
4/17/2023	David P. Southwell	Director	Sell	11,429	$51.03	$583,221.87	10,500
4/17/2023	Mark Elliott Boulding	VP	Sell	61,923	$51.42	$3,184,080.66	75,378
3/31/2023	David P. Southwell	Director	Sell	2,571	$50.05	$128,678.55	10,500
3/29/2023	Christine Marie Utter	CAO	Sell	4,688	$47.79	$224,039.52	38,059
3/27/2023	Christine Marie Utter	CAO	Sell	26,658	$45.09	$1,202,009.22	38,059
3/27/2023	David P. Southwell	Director	Sell	10,000	$45.10	$451,000.00	10,500
3/27/2023	Emily Luisa Hill	CFO	Sell	7,363	$45.00	$331,335.00	38,925
1/31/2023	Christine Marie Utter	CAO	Sell	325	$45.63	$14,829.75	38,059
1/31/2023	Emily Luisa Hill	CFO	Sell	575	$45.63	$26,237.25	46,288
1/31/2023	Eric Pauwels	Insider	Sell	375	$45.63	$17,111.25	65,537
1/31/2023	Mark Elliott Boulding	VP	Sell	812	$45.63	$37,051.56	75,378
1/31/2023	Stuart Walter Peltz	CEO	Sell	2,320	$45.63	$105,861.60	166,962
1/24/2023	Emily Luisa Hill	CFO	Sell	223	$47.45	$10,581.35	46,863
1/24/2023	Eric Pauwels	Insider	Sell	359	$47.45	$17,034.55	65,912
1/24/2023	Stuart Walter Peltz	CEO	Sell	284	$47.45	$13,475.80	55,204
1/11/2023	Christine Marie Utter	CAO	Sell	417	$44.36	$18,498.12	38,384
1/11/2023	Emily Luisa Hill	CFO	Sell	418	$44.36	$18,542.48	47,086
1/11/2023	Mark Elliott Boulding	VP	Sell	495	$44.36	$21,958.20	76,190
1/11/2023	Matthew B. Klein	COO	Sell	2,244	$44.36	$99,543.84	77,856
1/11/2023	Neil Gregory Almstead	Insider	Sell	383	$44.36	$16,989.88	64,579
1/11/2023	Stuart Walter Peltz	CEO	Sell	1,189	$44.36	$52,744.04	169,282
1/9/2023	Christine Marie Utter	CAO	Sell	706	$41.66	$29,411.96	39,290
1/9/2023	Emily Luisa Hill	CFO	Sell	758	$41.66	$31,578.28	48,001
1/9/2023	Mark Elliott Boulding	VP	Sell	835	$41.66	$34,786.10	77,275
1/9/2023	Matthew B. Klein	COO	Sell	731	$41.66	$30,453.46	82,373
1/9/2023	Neil Gregory Almstead	Insider	Sell	716	$41.66	$29,828.56	65,435
1/9/2023	Stuart Walter Peltz	CEO	Sell	1,786	$41.66	$74,404.76	171,699

SEC Filings (Institutional Ownership Changes) for PTC Therapeutics (NASDAQ:PTCT)

Institutional Buying and Selling by Quarter

PTC Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/2/2025	IFP Advisors Inc	765	$47K	0.0%	+68.1%	0.001%
12/1/2025	Cambria Investment Management L.P.	11,634	$0.71M	0.0%	+24.9%	0.014%
11/21/2025	CIBC Bancorp USA Inc.	8,285	$0.51M	0.0%	N/A	0.010%
11/20/2025	Wilmington Savings Fund Society FSB	1,074	$66K	0.0%	-20.5%	0.001%
11/19/2025	Danske Bank A S	18,774	$1.15M	0.0%	N/A	0.023%
11/17/2025	Armistice Capital LLC	3,277,272	$201.13M	3.0%	-30.8%	4.082%
11/17/2025	CANADA LIFE ASSURANCE Co	33,984	$2.06M	0.0%	+55.9%	0.042%
11/17/2025	Woodline Partners LP	105,605	$6.48M	0.0%	N/A	0.132%
11/17/2025	Voloridge Investment Management LLC	159,596	$9.79M	0.0%	-34.5%	0.199%
11/17/2025	Verition Fund Management LLC	37,070	$2.28M	0.0%	-67.9%	0.046%
11/17/2025	Qube Research & Technologies Ltd	430,934	$26.45M	0.0%	+27.4%	0.537%
11/17/2025	Palo Alto Investors LP	862,613	$52.94M	9.8%	+112.2%	1.074%
11/17/2025	Parkman Healthcare Partners LLC	202,363	$12.42M	1.3%	+11.4%	0.252%
11/17/2025	New Vernon Capital Holdings II LLC	3,675	$0.23M	0.1%	N/A	0.005%
11/17/2025	Mariner LLC	8,745	$0.54M	0.0%	+5.1%	0.011%
11/17/2025	Measured Wealth Private Client Group LLC	4,698	$0.29M	0.1%	N/A	0.006%
11/17/2025	Mercer Global Advisors Inc. ADV	14,385	$0.88M	0.0%	N/A	0.018%
11/17/2025	Millennium Management LLC	1,056,481	$64.84M	0.0%	-80.4%	1.316%
11/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	54,592	$3.35M	0.0%	-9.4%	0.068%
11/17/2025	Gotham Asset Management LLC	18,056	$1.11M	0.0%	-49.3%	0.022%
11/17/2025	Boxer Capital Management LLC	200,000	$12.27M	3.9%	N/A	0.249%
11/17/2025	Brevan Howard Capital Management LP	13,486	$0.83M	0.0%	-73.2%	0.017%
11/17/2025	Cinctive Capital Management LP	95,308	$5.85M	0.3%	N/A	0.119%
11/14/2025	Schonfeld Strategic Advisors LLC	23,173	$1.42M	0.0%	-45.2%	0.029%
11/14/2025	Creative Planning	30,924	$1.90M	0.0%	+24.6%	0.039%
11/14/2025	SummitTX Capital L.P.	102,734	$6.31M	0.3%	+638.7%	0.128%
11/14/2025	Raymond James Financial Inc.	83,125	$5.10M	0.0%	-3.0%	0.104%
11/14/2025	Bellevue Group AG	2,530	$0.16M	0.0%	-33.4%	0.003%
11/14/2025	Man Group plc	265,181	$16.27M	0.0%	-60.5%	0.330%
11/14/2025	Zurcher Kantonalbank Zurich Cantonalbank	20,931	$1.29M	0.0%	-31.6%	0.026%
11/14/2025	UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC	129,898	$7.97M	0.0%	-43.4%	0.162%
11/14/2025	Two Sigma Investments LP	24,341	$1.49M	0.0%	-52.1%	0.030%
11/14/2025	Bridgeway Capital Management LLC	41,800	$2.57M	0.1%	N/A	0.052%
11/14/2025	Wellington Management Group LLP	4,918,619	$301.86M	0.1%	+4.8%	6.126%
11/14/2025	Arrowpoint Investment Partners Singapore Pte. Ltd.	3,291	$0.20M	0.2%	N/A	0.004%
11/14/2025	Comerica Bank	523	$32K	0.0%	+868.5%	0.001%
11/14/2025	FORA Capital LLC	5,827	$0.36M	0.1%	N/A	0.007%
11/13/2025	Boston Partners	361,664	$22.20M	0.0%	N/A	0.450%
11/13/2025	Marshall Wace LLP	157,739	$9.68M	0.0%	-70.7%	0.196%
11/13/2025	Vise Technologies Inc.	9,086	$0.56M	0.0%	-8.6%	0.011%
11/13/2025	LGL Partners LLC	17,067	$1.05M	0.4%	+6.7%	0.021%
11/13/2025	Arrowstreet Capital Limited Partnership	323,548	$19.86M	0.0%	+851.6%	0.403%
11/13/2025	Invesco Ltd.	313,057	$19.21M	0.0%	+3.2%	0.390%
11/13/2025	Sei Investments Co.	58,341	$3.58M	0.0%	-15.5%	0.073%
11/13/2025	UBS Group AG	452,209	$27.75M	0.0%	-21.9%	0.563%
11/13/2025	BNP Paribas Financial Markets	20,147	$1.24M	0.0%	+56.1%	0.025%
11/13/2025	Mackenzie Financial Corp	201,792	$12.38M	0.0%	+667.7%	0.251%
11/13/2025	Legal & General Group Plc	241,342	$14.81M	0.0%	+8.3%	0.301%
11/13/2025	Vestcor Inc	13,017	$0.80M	0.0%	+167.1%	0.016%
11/13/2025	Swiss National Bank	138,265	$8.49M	0.0%	+2.0%	0.172%
11/13/2025	Russell Investments Group Ltd.	247,493	$15.19M	0.0%	+87.9%	0.308%
11/13/2025	Schroder Investment Management Group	34,122	$2.07M	0.0%	N/A	0.042%
11/13/2025	Jefferies Financial Group Inc.	1,584,678	$97.25M	0.5%	N/A	1.974%
11/13/2025	Pinnacle Associates Ltd.	88,592	$5.44M	0.1%	-4.2%	0.110%
11/13/2025	B. Metzler seel. Sohn & Co. AG	15,382	$0.94M	0.0%	N/A	0.019%
11/13/2025	Natixis Advisors LLC	12,750	$0.78M	0.0%	N/A	0.016%
11/13/2025	First Trust Advisors LP	121,855	$7.48M	0.0%	-2.8%	0.152%
11/13/2025	Neo Ivy Capital Management	18,880	$1.16M	0.3%	-18.2%	0.024%
11/12/2025	Barclays PLC	239,649	$14.71M	0.0%	-14.4%	0.298%
11/12/2025	Dimensional Fund Advisors LP	773,178	$47.45M	0.0%	+46.6%	0.963%
11/12/2025	Teachers Retirement System of The State of Kentucky	21,858	$1.34M	0.0%	-10.4%	0.027%
11/12/2025	Victory Capital Management Inc.	76,113	$4.67M	0.0%	+5.5%	0.095%
11/12/2025	Focus Partners Advisor Solutions LLC	3,033	$0.19M	0.0%	N/A	0.004%
11/12/2025	Segall Bryant & Hamill LLC	37,462	$2.30M	0.0%	-0.7%	0.047%
11/12/2025	Royce & Associates LP	32,779	$2.01M	0.0%	-34.8%	0.041%
11/12/2025	Rafferty Asset Management LLC	101,001	$6.20M	0.0%	+3.5%	0.126%
11/12/2025	Quantbot Technologies LP	1,099	$67K	0.0%	-55.6%	0.001%
11/12/2025	Handelsbanken Fonder AB	28,100	$1.72M	0.0%	+24.9%	0.035%
11/12/2025	Private Capital Advisors Inc.	16,062	$0.99M	0.1%	N/A	0.020%
11/12/2025	Intech Investment Management LLC	28,278	$1.74M	0.0%	-28.1%	0.035%
11/12/2025	US Bancorp DE	1,089	$67K	0.0%	-65.6%	0.001%
11/10/2025	Optiver Holding B.V.	507	$31K	0.0%	+96.5%	0.001%
11/10/2025	EverSource Wealth Advisors LLC	847	$52K	0.0%	-25.9%	0.001%
11/10/2025	Ameritas Investment Partners Inc.	6,494	$0.40M	0.0%	-18.2%	0.008%
11/10/2025	Brummer Multi Strategy AB	19,142	$1.18M	21.4%	N/A	0.024%
11/10/2025	Hillsdale Investment Management Inc.	91,136	$5.59M	0.2%	-15.4%	0.114%
11/10/2025	Empirical Financial Services LLC d.b.a. Empirical Wealth Management	20,775	$1.28M	0.0%	N/A	0.026%
11/10/2025	China Universal Asset Management Co. Ltd.	13,924	$0.86M	0.1%	-12.5%	0.017%
11/7/2025	Syon Capital LLC	3,694	$0.23M	0.0%	N/A	0.005%
11/7/2025	GSA Capital Partners LLP	5,326	$0.33M	0.0%	-82.8%	0.007%
11/7/2025	denkapparat Operations GmbH	5,958	$0.37M	0.2%	N/A	0.008%
11/7/2025	Vanguard Group Inc.	8,288,999	$508.70M	0.0%	-6.3%	10.435%
11/7/2025	JPMorgan Chase & Co.	490,934	$30.13M	0.0%	-18.4%	0.618%
11/7/2025	State of New Jersey Common Pension Fund D	43,480	$2.67M	0.0%	+5.1%	0.055%
11/7/2025	Shell Asset Management Co.	451	$28K	0.0%	-60.8%	0.001%
11/7/2025	GF Fund Management CO. LTD.	1,709	$0.11M	0.0%	-13.4%	0.002%
11/6/2025	LSV Asset Management	2,700	$0.17M	0.0%	N/A	0.003%
11/6/2025	Rhumbline Advisers	113,904	$6.99M	0.0%	-3.9%	0.143%
11/6/2025	Profund Advisors LLC	22,262	$1.37M	0.0%	+6.8%	0.028%
11/6/2025	ProShare Advisors LLC	16,120	$0.99M	0.0%	-14.7%	0.020%
11/6/2025	Candriam S.C.A.	146,265	$8.98M	0.0%	-1.6%	0.184%
11/5/2025	Plato Investment Management Ltd	917	$56K	0.0%	-51.5%	0.001%
11/5/2025	Smartleaf Asset Management LLC	469	$28K	0.0%	+101.3%	0.001%
11/5/2025	Alps Advisors Inc.	36,873	$2.26M	0.0%	-13.7%	0.046%
11/5/2025	BI Asset Management Fondsmaeglerselskab A S	95,005	$5.83M	0.1%	-24.7%	0.120%
11/5/2025	Savant Capital LLC	8,992	$0.55M	0.0%	+8.6%	0.011%
11/4/2025	Allianz Asset Management GmbH	8,300	$0.51M	0.0%	+9.2%	0.010%
11/4/2025	WCM Investment Management LLC	147,065	$8.92M	0.0%	N/A	0.185%
11/4/2025	State of Wyoming	10,870	$0.67M	0.1%	+204.2%	0.014%
11/4/2025	Convergence Investment Partners LLC	27,928	$1.71M	0.4%	+13.2%	0.035%

Data available starting January 2016

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders in the United States and internationally. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy; Upstaza to treat aromatic l-amino acid decarboxylas (AADC) deficiency, a central nervous system disorder; Tegsedi and Waylivra for the treatment of rare diseases; and Evrysdi to treat spinal muscular atrophy (SMA) in adults and children. Its development pipeline products include Sepiapterin for the treatment of phenylketonuria; PTC518 splicing platform, which is being developed for the treatment of Huntington's disease; and ferroptosis and inflammation platforms, including vatiquinone to treat Friedreich ataxia and utreloxastat for the treatment of amyotrophic lateral sclerosis. The company distributes its products through third-party distributors. It has collaborations with F. Hoffman-La Roche Ltd, Hoffman-La Roche Inc., the SMA Foundation, National Taiwan University, Akcea Therapeutics, Inc., and Shiratori Pharmaceutical Co., Ltd. PTC Therapeutics, Inc. was incorporated in 1998 and is headquartered in South Plainfield, New Jersey.

Today's Range

Now: $77.85

$74.83

$79.03

50 Day Range

MA: $70.85

$58.99

$86.25

52 Week Range

Now: $77.85

$35.95

$87.50

Volume

1,615,845 shs

Average Volume

2,293,989 shs

Market Capitalization

$6.25 billion

P/E Ratio

9.09

Dividend Yield

N/A

Beta

0.47

Who are the company insiders with the largest holdings of PTC Therapeutics?: PTC Therapeutics' top insider shareholders include:
Matthew B Klein (CEO)
Michael Schmertzler (Director)
Mark Elliott Boulding (VP)
Neil Gregory Almstead (Insider)
Eric Pauwels (CEO)
Lee Scott Golden (EVP)
Pierre Gravier (CFO)
Eric Pauwels (Insider)
Christine Marie Utter (CAO)
Allan Steven Jacobson (Director)
David P Southwell (Director)
Jerome B Zeldis (Director)
Emma Reeve (Director)
Stephanie Okey (Director)
Learn More about top insider investors at PTC Therapeutics.
Who are the major institutional investors of PTC Therapeutics?: PTC Therapeutics' top institutional investors include:
Vanguard Group Inc. — 10.43%
Wellington Management Group LLP — 6.13%
Armistice Capital LLC — 4.08%
Jefferies Financial Group Inc. — 1.97%
Millennium Management LLC — 1.32%
Palo Alto Investors LP — 1.07%
Learn More about top institutional investors of PTC Therapeutics stock.
Which major investors are selling PTC Therapeutics stock?: During the previous quarter, PTCT stock was sold by these institutional investors:
Millennium Management LLC
Armistice Capital LLC
Vanguard Group Inc.
Assenagon Asset Management S.A.
Man Group plc
Marshall Wace LLP
Pacer Advisors Inc.
UBS Group AG
Within the previous year, company insiders that have sold PTC Therapeutics company stock include:
Matthew B Klein (CEO)
Michael Schmertzler (Director)
Mark Elliott Boulding (VP)
Neil Gregory Almstead (Insider)
Eric Pauwels (CEO)
Lee Scott Golden (EVP)
Pierre Gravier (CFO)
Eric Pauwels (Insider)
Christine Marie Utter (CAO)
Allan Steven Jacobson (Director)
David P Southwell (Director)
Jerome B Zeldis (Director)
Learn More investors selling PTC Therapeutics stock.
Which major investors are buying PTC Therapeutics stock?: Within the previous quarter, PTCT stock was bought by institutional investors including:
Jefferies Financial Group Inc.
Palo Alto Investors LP
Boston Partners
Arrowstreet Capital Limited Partnership
Dimensional Fund Advisors LP
Wellington Management Group LLP
Boxer Capital Management LLC
Mackenzie Financial Corp